Cortical γ-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence : Relationship to features of alcohol dependence and cigarette smoking

CONTEXT Adaptations in gamma-aminobutyric acid type A (GABA(A))-benzodiazepine receptors contribute to the neurobiology of human alcohol dependence and withdrawal. OBJECTIVE To study GABA(A)-benzodiazepine receptor adaptations in subjects with alcohol dependence over the first month of sobriety. DESIGN Inpatients who were not receiving medication, were either smokers or nonsmokers, and had alcohol dependence completed 2 iodine I 123-labeled iomazenil single-photon emission computed tomographic scans: 1 scan at a mean +/- SD of 4.9 +/- 2.5 days of sobriety (n = 23) and 1 scan at a mean +/- SD of 29.8 +/- 7.6 days of sobriety (n = 20). Participants in a matched group of healthy subjects (n = 15) completed 1 single-photon emission computed tomographic scan. PARTICIPANTS Men with alcohol dependence (n = 27) and a matched healthy comparison group (n = 15). MAIN OUTCOME MEASURES (123)I-iomazenil single-photon emission computed tomographic images were converted to units of distribution volume (regional activity/free (123)I-iomazenil) and were analyzed using voxel-based statistical parametric mapping and regions of interest analyses. The relationships between (123)I-iomazenil distribution volume, clinical features of alcohol dependence, and smoking status were evaluated. RESULTS (123)I-iomazenil uptake was elevated in several cortical regions, with a more prominent increase in nonsmokers with alcohol dependence as compared with smokers with alcohol dependence at 1 week of abstinence from alcohol. No significant differences were observed at 4 weeks of abstinence. At 1 week of abstinence, frontal (123)I-iomazenil uptake correlated with the severity of alcohol withdrawal and the number of days since the last alcoholic drink was consumed. No significant associations were observed for smokers with alcohol dependence. CONCLUSIONS These data demonstrate time-dependent regulation of cortical GABA(A)-benzodiazepine receptors associated with the recovery from alcohol dependence. Higher GABA(A)-benzodiazepine receptor levels during acute withdrawal may reflect a compensation for reduced receptor function, which is thought to contribute to alcohol tolerance and withdrawal. The subsequent decline may reflect "normalization" of GABA(A) receptor function with sobriety. Smoking may attenuate GABA(A) receptor adaptations associated with alcohol dependence and may contribute to the comorbidity between alcoholism and smoking.

[1]  D. Crane,et al.  GABAa receptor α‐subunit proteins in human chronic alcoholics , 2001 .

[2]  I G Zubal,et al.  Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  L. Kozlowski,et al.  Effect of cigarette smoking on alcohol treatment outcome. , 1995, Journal of substance abuse.

[4]  N. Volkow,et al.  Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.

[5]  J. Kralic,et al.  Chronic ethanol consumption enhances internalization of α1 subunit‐containing GABAA receptors in cerebral cortex , 2003, Journal of neurochemistry.

[6]  J L Lancaster,et al.  Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.

[7]  G. Freund,et al.  Decrease of benzodiazepine receptors in frontal cortex of alcoholics. , 1988, Alcohol.

[8]  A. Morrow,et al.  Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis. , 1995, Molecular pharmacology.

[9]  P B Hoffer,et al.  Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J. Kril,et al.  Receptor binding sites and uptake activities mediating GABA neurotransmission in chronic alcoholics with Wernicke encephalopathy , 1996, Brain Research.

[11]  M. Hariharan,et al.  A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. , 1988, Clinical chemistry.

[12]  D. Crane,et al.  Expression of the α 1, α 2 and α 3 isoforms of the GABAA receptor in human alcoholic brain , 1997, Brain Research.

[13]  A. Morrow,et al.  Differential effects of chronic ethanol administration on GABAA receptor α1 and α6 subunit mRNA levels in rat cerebellum , 1992, Molecular and Cellular Neuroscience.

[14]  E. Sybirska,et al.  SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  J. Kril,et al.  Amino Acid Neurotransmitter Receptor Changes in Cerebral Cortex in Alcoholism: Effect of Cirrhosis of the Liver , 1992, Journal of neurochemistry.

[16]  S H Snyder,et al.  GABA receptors are increased in brains of alcoholics , 1981, Annals of neurology.

[17]  Jimmy D Bell,et al.  Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis , 2000, Gut.

[18]  S. Paul,et al.  Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex. , 1991, Molecular pharmacology.

[19]  R. Harris,et al.  Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol. , 1990, The Journal of pharmacology and experimental therapeutics.

[20]  J. Nurnberger,et al.  Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. The Collaborative Study Group on the Genetics of Alcoholism. , 2000, Alcohol and alcoholism.

[21]  M. Smolka,et al.  The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. , 2002, European journal of pharmacology.

[22]  J. Krystal,et al.  Sex, GABA, and nicotine: The impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy , 2005, Biological Psychiatry.

[23]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[24]  D. B. Matthews,et al.  The role of GABAA receptors in the acute and chronic effects of ethanol , 1998, Psychopharmacology.

[25]  G. Freund,et al.  Loss of muscarinic and benzodiazepine neuroreceptors from hippocampus of alcohol abusers. , 1989, Alcohol.

[26]  K. Brady,et al.  Update on anticonvulsants for the treatment of alcohol withdrawal. , 2001, The American journal on addictions.

[27]  S. Woods,et al.  Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: potential probe for SPECT brain imaging. , 1990, Life sciences.

[28]  S. Woods,et al.  SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154. , 1991, European journal of pharmacology.

[29]  A. Morrow,et al.  Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. , 1996, The Journal of pharmacology and experimental therapeutics.

[30]  N. Martin,et al.  Alcohol sensitivity and smoking history in men and women. , 1995, Alcoholism, clinical and experimental research.

[31]  Sid Gilman,et al.  Positron emission tomographic studies of cerebral benzodiazepine‐receptor binding in chronic alcoholics , 1996, Annals of neurology.

[32]  G. Biggio,et al.  Changes in Gaba a Receptor Gene Expression Associated with Selective Alterations in Receptor Function and Pharmacology after Ethanol Withdrawal , 2022 .

[33]  S. Woods,et al.  Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans. , 1999, European journal of pharmacology.

[34]  E. Sybirska,et al.  SPECT Imaging of the benzodiazepine receptor: Autoradiographic comparison of receptor density and radioligand distribution , 1992, Synapse.

[35]  J. T. Sullivan,et al.  Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale. , 1991, Journal of clinical psychopharmacology.

[36]  N. Volkow,et al.  Decreased cerebral response to inhibitory neurotransmission in alcoholics. , 1993, The American journal of psychiatry.

[37]  J. Krystal,et al.  NMDA Receptor Antagonism and the Ethanol Intoxication Signal , 2003, Annals of the New York Academy of Sciences.

[38]  J S Fowler,et al.  Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification. , 1997, Alcoholism, clinical and experimental research.

[39]  A. Leslie Morrow,et al.  Regional variations in the effects of chronic ethanol administration on GABAA receptor expression: potential mechanisms , 2000, Neurochemistry International.

[40]  M. Airaksinen,et al.  Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites. , 1980, Medical biology.

[41]  Linda C. Sobell,et al.  Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption , 1992 .

[42]  H. Aubin,et al.  Changes in cigarette smoking and coffee drinking after alcohol detoxification in alcoholics. , 1999, Addiction.

[43]  P. Seeburg,et al.  Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. , 1989, Science.

[44]  N. Volkow,et al.  Brain monoamine oxidase A inhibition in cigarette smokers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M Laruelle,et al.  Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. , 1998, The American journal of psychiatry.

[46]  P. Jenner Hidden persuasion , 1996, Human & experimental toxicology.

[47]  C. Naranjo,et al.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). , 1989, British journal of addiction.

[48]  R. Harris,et al.  Subunit mutations affect ethanol actions on GABAA receptors expressed in Xenopus oocytes , 1999, British journal of pharmacology.

[49]  L. Pieri,et al.  In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[50]  J. Kril,et al.  Necropsy study of GABA/benzodiazepine receptor binding sites in brain tissue from chronic alcoholic patients. , 1988, Clinical and experimental neurology.

[51]  J. Littleton,et al.  Current concepts of ethanol dependence. , 1994, Addiction.

[52]  A. Lingford-Hughes,et al.  Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography study. , 2000, Alcoholism, clinical and experimental research.

[53]  M. Ticku,et al.  Chronic ethanol administration alters gamma-aminobutyric acidA receptor gene expression. , 1992, Molecular pharmacology.

[54]  J. Seibyl,et al.  SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  E. Sybirska,et al.  Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[56]  S. Tiffany,et al.  The development of a cocaine craving questionnaire. , 1993, Drug and alcohol dependence.

[57]  R. Olsen Drug interactions at the GABA receptor-ionophore complex. , 1982, Annual review of pharmacology and toxicology.

[58]  W. Sieghart,et al.  Antibodies Specific for GABAA Receptor α Subunits Reveal that Chronic Alcohol Treatment Down‐Regulates α‐Subunit Expression in Rat Brain Regions , 1993 .

[59]  J. Brioni,et al.  Benzodiazepine receptor mediation of the anxiolytic-like effect of (−)-nicotine in mice , 1994, Pharmacology Biochemistry and Behavior.

[60]  P W Woodruff,et al.  Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy , 1998, British Journal of Psychiatry.

[61]  R. Harris,et al.  Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors , 1997, Nature.

[62]  H. Rommelspacher,et al.  Benzodiazepine antagonism by harmane and other β-carbolines in vitro and in vivo , 1981 .

[63]  H. Rommelspacher,et al.  1-Methyl-β-carboline (Harmane), a potent endogenous inhibitor of benzodiazepine receptor binding , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

[64]  M. Davies The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. , 2003, Journal of psychiatry & neuroscience : JPN.

[65]  K. Mann,et al.  Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking. , 1996, Life sciences.

[66]  Jan-Eric Litton,et al.  PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls , 1993, Psychiatry Research: Neuroimaging.

[67]  M. Pawlik,et al.  [3H]Harman Binding Experiments. I: A Reversible and Selective Radioligand for Monoamine Oxidase Subtype A in the CNS of the Rat , 1991, Journal of neurochemistry.

[68]  S. Paul,et al.  Beta-carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors. , 1982, Journal of medicinal chemistry.

[69]  Harvey A. Skinner,et al.  Alcohol Dependence Scale (ADS): User's guide. , 1984 .

[70]  Jack L. Lancaster,et al.  The Talairach Daemon a database server for talairach atlas labels , 1997 .

[71]  C. Pomerleau,et al.  Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. , 1994, Addictive behaviors.

[72]  N. Volkow,et al.  Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. , 1998, Journal of addictive diseases.

[73]  D. B. Matthews,et al.  The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence , 2001, Brain Research Reviews.

[74]  P. Monti,et al.  Smoking and drinking among alcoholics in treatment: cross-sectional and longitudinal relationships. , 2000, Journal of studies on alcohol.